Evidence map›Paper›PMID 34072461›Full record

ReviewMaterials (Basel, Switzerland)2021

Application of Advanced Nanomaterials for Kidney Failure Treatment and Regeneration.

Aziz Eftekhari, Solmaz Maleki Dizaj, Elham Ahmadian, Agata Przekora, Seyed Mahdi Hosseiniyan Khatibi, Mohammadreza Ardalan, Sepideh Zununi Vahed, Mahbuba Valiyeva, Sevil Mehraliyeva, Rovshan Khalilov and 1 more

Open access · goldAbstract readReview
In one paragraph

Review in Materials (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
8.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 58 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Future Frontiers in Bioinspired Implanted Biomaterials.Advanced materials (Deerfield Beach, Fla.) · 2025
    Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. COUP-TFII in Kidneys, from Embryos to Sick Adults.Diagnostics (Basel, Switzerland) · 2022
    Review
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 4 countries.

Aziz EftekhariPharmacology and Toxicology Department, Maragheh University of Medical Sciences, Maragheh 7815155158, Iran.
Solmaz Maleki DizajDental and Periodontal Research Center, Tabriz University of Medical Sciences, Tabriz 5166614756, Iran.ORCID 0000-0003-4759-7222
Elham AhmadianKidney Research Center, Tabriz University of Medical Sciences, Tabriz 5166614756, Iran.ORCID 0000-0002-7230-0489
Agata PrzekoraChair and Department of Biochemistry and Biotechnology, Medical University of Lublin, Chodzki 1 Street, 20-093 Lublin, Poland.ORCID 0000-0002-6076-1309
Seyed Mahdi Hosseiniyan KhatibiKidney Research Center, Tabriz University of Medical Sciences, Tabriz 5166614756, Iran.
Mohammadreza ArdalanKidney Research Center, Tabriz University of Medical Sciences, Tabriz 5166614756, Iran.ORCID 0000-0002-6851-5460
Sepideh Zununi VahedKidney Research Center, Tabriz University of Medical Sciences, Tabriz 5166614756, Iran.ORCID 0000-0003-0179-4562
Mahbuba ValiyevaDepartment of Pharmaceutical Technology and Management, Azerbaijan Medical University, AZ 1022 Baku, Azerbaijan.
Sevil MehraliyevaDepartment of Pharmaceutical Technology and Management, Azerbaijan Medical University, AZ 1022 Baku, Azerbaijan.
Rovshan KhalilovRussian Institute for Advanced Study, Moscow State Pedagogical University, 1/1, Malaya Pirogovskaya St., 119991 Moscow, Russia.
Mohammad HasanzadehPharmaceutical Analysis Research Center, Tabriz University of Medical Sciences, Tabriz 5166614756, Iran.ORCID 0000-0003-4918-1239
Tabriz University of Medical Sciences · IRAzerbaijan Medical University · AZAzerbaijan National Academy of Sciences · AZMedical University of Lublin · PLUniversity of Maragheh · IR

Funding

Ministry of Education and Science in Poland DS3/2021
6 · The paper itself

Abstract

The implementation of nanomedicine not only provides enhanced drug solubility and reduced off-target adverse effects, but also offers novel theranostic approaches in clinical practice. The increasing number of studies on the application of nanomaterials in kidney therapies has provided hope in a more efficient strategy for the treatment of renal diseases. The combination of biotechnology, material science and nanotechnology has rapidly gained momentum in the realm of therapeutic medicine. The establishment of the bedrock of this emerging field has been initiated and an exponential progress is observed which might significantly improve the quality of human life. In this context, several approaches based on nanomaterials have been applied in the treatment and regeneration of renal tissue. The presented review article in detail describes novel strategies for renal failure treatment with the use of various nanomaterials (including carbon nanotubes, nanofibrous membranes), mesenchymal stem cells-derived nanovesicles, and nanomaterial-based adsorbents and membranes that are used in wearable blood purification systems and synthetic kidneys.

Indexed as

carbon nanotubeselectrospinningexosomeskidney regenerationnanofibersnanovesiclessynthetic kidneytherapeutic nanomedicine

Identifiers

PMID34072461
PMCPMC8198057
OpenAlexW3164279501

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.